HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cyrillo G Brahm Selected Research

RGB 286638

1/2020Data-driven prioritization and preclinical evaluation of therapeutic targets in glioblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cyrillo G Brahm Research Topics

Disease

2Glioblastoma (Glioblastoma Multiforme)
01/2022 - 12/2018
2Neoplasms (Cancer)
01/2022 - 01/2020

Drug/Important Bio-Agent (IBA)

1Tyrosine Kinase InhibitorsIBA
01/2022
1Pharmaceutical PreparationsIBA
01/2022
1PhosphopeptidesIBA
01/2022
1Sunitinib (Sutent)FDA Link
01/2022
1Phosphotransferases (Kinase)IBA
01/2022
1PhosphotyrosineIBA
01/2022
1RGB 286638IBA
01/2020
1Messenger RNA (mRNA)IBA
01/2020

Therapy/Procedure

1Chemoradiotherapy
12/2018